Antibe Therapeutics Inc. (ATE.TO) - Stock Prices, Stock Peers & Analysis

Home
ATE.TO

Company Name	Antibe Therapeutics Inc.
Symbol	ATE.TO
Currency	CAD
Price	0.295
Market Cap Market Cap The market capitalization (market cap) of a stock represents the total market value of a company's outstanding shares of stock. It's a key metric used to gauge a company's size and investment risk, and it can be an important factor in investment decisions. Here's how it's calculated: Market Cap = Number of Outstanding Shares × Current Share Price	15,637,773
Dividend Yield Dividend Yield The dividend yield is a financial ratio that measures the amount of cash dividends distributed to common shareholders relative to the market value per share. The dividend yield is represented as a percentage and can be calculated by dividing the dollar value of dividends paid in a given year per share of stock held by the dollar value of one share of stock. Here's how it's calculated: Dividend Yield = Annual Dividends per Share / Price per Share	0%
52-week-range	0.15 - 1.23
Industry	Medical Devices
Sector	Healthcare
CEO	Mr. Daniel Marcel Legault J.D., L.L.B.
Website	https://www.antibethera.com

An error occurred while fetching data.

About Antibe Therapeutics Inc.

Antibe Therapeutics Inc., a biotechnology company, engages in developing novel therapeutics and medical devices in the areas of pain, inflammation and regenerative medicine in Canada, Europe, the United States, and internationally. The company's drugs are designed to prevent the gastrointestinal damage and bleeding caused by non-steroidal anti-inflammatory drugs. Its lead